Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

BioCorRx (BICX) Accumulated Depreciation & Amortization (2016 - 2025)

BioCorRx (BICX) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $190489.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 8.49% to $190489.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $190489.0 through Dec 2025, up 8.49% year-over-year, with the annual reading at $190489.0 for FY2025, 8.49% up from the prior year.
  • Accumulated Depreciation & Amortization hit $190489.0 in Q4 2025 for BioCorRx, down from $194551.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $194551.0 in Q3 2025 to a low of $71222.0 in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $134386.6 across 5 years, with a median of $133978.5 in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 174.52% in 2021 and later grew 8.49% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $91708.0 in 2021, then increased by 28.65% to $117979.0 in 2022, then increased by 21.72% to $143608.0 in 2023, then rose by 22.26% to $175574.0 in 2024, then rose by 8.49% to $190489.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BICX at $190489.0 in Q4 2025, $194551.0 in Q3 2025, and $183468.0 in Q2 2025.